The best source of evidence to base one’s clinical decisions on is a well-designed prospective randomized masked controlled clinical trial.
These clinical trials represent level I evidence, and if two or three well-designed prospective clinical trials produce similar evidence, the likelihood that the evidence is accurate is very strong.
In the anterior segment world, the majority of our prospective clinical trials are designed and funded by industry. In the retina world, many high-quality clinical trials are initiated, designed and completed by clinician scientists in collaboration with
Uncategorized